<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Korean Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25045239</article-id>
      <article-id pub-id-type="pmc">4101771</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2014.29.7.1021</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group subj-group-type="heading">
            <subject>Neuroscience</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The Significance of Clinical and Laboratory Features in the Diagnosis of Glycogen Storage Disease Type V: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4165-8901</contrib-id>
          <name>
            <surname>Park</surname>
            <given-names>Hyung Jun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4408-8265</contrib-id>
          <name>
            <surname>Shin</surname>
            <given-names>Ha Young</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2865-6012</contrib-id>
          <name>
            <surname>Cho</surname>
            <given-names>Yu Na</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4384-9640</contrib-id>
          <name>
            <surname>Kim</surname>
            <given-names>Seung Min</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5525-6861</contrib-id>
          <name>
            <surname>Choi</surname>
            <given-names>Young-Chul</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Neurology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A3"><label>3</label>Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Address for Correspondence: Young-Chul Choi, MD. Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, 612 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea. Tel: +82.2-2019-3323, Fax: +82.2-3462-5904, <email>ycchoi@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>29</volume>
      <issue>7</issue>
      <fpage>1021</fpage>
      <lpage>1024</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>10</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2014 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Glycogen storage disease type V (GSD-V) is the most common disorder of muscle glycogenosis with characteristic clinical and laboratory findings. A 32-yr-old woman complained of exercise intolerance and myoglobulinuria since early adolescence. She reported several episodes of second-wind phenomenon. Physical examination did not show any neurological abnormality, including fixed muscle weakness or atrophy. Serum creatine kinase level was 1,161 IU/L at rest. The result of the non-ischemic forearm exercise test was compatible with GSD-V. Mutation analysis identified the compound heterozygous mutations of the <italic>PYGM</italic>, p.D510fs and p.F710del, which has not yet been reported in Korea. The present case recognizes that detail clinical and laboratory analysis is the first step in the diagnosis of GSD-V.</p>
        <sec>
          <title>Graphical Abstract</title>
          <p>
            <graphic xlink:href="jkms-29-1021-ab001.jpg" position="float" orientation="portrait"/>
          </p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Glycogen Storage Disease Type V</kwd>
        <kwd>McArdle's Disease</kwd>
        <kwd>Phosphorylase, Glycogen, Muscle (<italic>PYGM</italic>)</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Glycogen storage disease type V (GSD-V), also known as McArdle's disease, is the most common disorder of muscle glycogenosis (<xref rid="B1" ref-type="bibr">1</xref>). GSD-V is caused by alterations in the <italic>PYGM</italic> which encodes myophosphorylase. Myophosphorylase catalyzes the phosphorolytic cleavage of glycogen to glucose-1-phosphate in skeletal muscle. Therefore, enzyme deficiency results in the defective breakdown of glycogen into glucose and glycogen accumulation in muscle (<xref rid="B2" ref-type="bibr">2</xref>).</p>
      <p>GSD-V is inherited in an autosomal recessive pattern, and the prevalence has been estimated at about 1 in 100,000-167,000 (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Most adult patients present with typical clinical features such as exercise intolerance, episodic myoglobulinuria and the second-wind phenomenon. In addition, the resting serum creatine kinase (CK) level, forearm exercise test, and electrophysiological studies can contribute to diagnosis. Subsequent mutation analysis and myophosphorylase activity assay can be used to confirm the diagnosis.</p>
      <p>There has only been one case report of Korean patients with GSD-V (<xref rid="B5" ref-type="bibr">5</xref>). However, the previous report did not feature typical clinical presentations of GSD-V such as myoglobulinuria and the second-wind phenomenon. Here, we report a Korean case of GSD-V with typical clinical and laboratory findings.</p>
    </sec>
    <sec>
      <title>CASE DESCRIPTION</title>
      <p>A 32-yr-old woman (<xref ref-type="fig" rid="F1">Fig. 1A</xref>, II-3) was referred to our clinic due to easy fatigability, muscle cramps and myoglobulinuria in June 2013. Her family history was unremarkable. She recalled easy fatigability, muscle cramps and contractures after intense exercise during physical education classes since early adolescence. In addition, she had several episodes of dark urine following intense exercise such as long-distance running. These symptoms of exercise intolerance had been aggravated one year before. She also reported marked improvement in exercise tolerance after about 20 min, a process termed the 'second-wind phenomenon'; specifically, she had seen improvement in excessive fatigue, breathlessness, and tachycardia. Physical examination did not show fixed muscle weakness and muscle atrophy. All of her sensory modalities and tendon reflexes were intact. Laboratory studies revealed a serum creatine kinase (CK) level of 1,161 IU/L (normal&lt;215 IU/L) at rest. Nerve conduction study (NCS) and needle electromyography study (EMG) did not show any abnormalities at rest. The non-ischemic forearm exercise test showed no increase in venous lactate level with a normal increase in ammonia (<xref ref-type="fig" rid="F2">Fig. 2</xref>). To confirm easy fatigability and weakness after exercise, we performed motor NCS on the ulnar nerve after voluntary maximal contraction for two minutes and 50 Hz nerve stimulations for one second. However, the amplitudes of the compound muscle action potentials did not decrease after maximal contraction and nerve stimulation. In addition, EMG did not show silent electrical activities during muscle cramps. Based on the clinical and laboratory features, she was diagnosed with glycogenoses with exercise-induced weakness, especially GSD-V. Therefore, we performed <italic>PYGM</italic> genotyping.</p>
      <sec>
        <title>Mutational analysis</title>
        <p>A DNA sample was extracted from peripheral leukocytes using the Quick Gene blood kit (Fujifilm, Tokyo, Japan). The primer set that covers all 20 exons and their flanking intron regions of the <italic>PYGM</italic> was designed with Primer 3web v.4.0 (<ext-link ext-link-type="uri" xlink:href="http://primer3.wi.mit.edu/">http://primer3.wi.mit.edu/</ext-link>) using sequences from the Gen Bank accession number NT_167190.1. All the exons of the <italic>PYGM</italic> were sequenced using BigDye Terminator v.3.1 (Applied Biosystems, Foster City, CA, USA) followed by polymerase chain reaction. Electrophoresis and analysis of the reaction mixtures were done with ABI3130xl Genetic Analyzer (Applied Biosystems). A compound heterozygous mutation was identified; one allele had a frameshift mutation of c.1531delG (p.D510fs) in exon 13 and the other allele had a deletion mutation of c.2128_2130delTTC (p.F710del) in exon 17 (<xref ref-type="fig" rid="F1">Fig. 1B</xref>). These mutations have been previously reported to be underlying causes of GSD-V in Japanese patients (<xref rid="B6" ref-type="bibr">6</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>We described a Korean patient with <italic>PYGM</italic> mutations who had typical clinical and laboratory findings for identification of GSD-V. Even though GSD-V is the most common disorder of muscle glycogenosis, our patient is only the second case of genetically proven GSD-V in Korea.</p>
      <p>Four characteristic clinical features are important for initial suspicion of GSD-V. First, exercise intolerance such as easy fatigability, muscle cramps and contractures is triggered by static contractions and dynamic exercise. Almost all patients are admitted to the hospital for exercise intolerance. The pathophysiology of exercise intolerance is not fully understood, but may be associated with impaired glycolysis (<xref rid="B2" ref-type="bibr">2</xref>). A deficient glycogen-dependent adenosine triphosphate (ATP) supply might result in down-regulation of Na<sup>+</sup>/K<sup>+</sup> pumps in myocytes, leading to loss of membrane excitability (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). The defective breakdown of glycogen into glucose is reproduced by the forearm exercise test. The forearm exercise test showed no increase in lactate level with a normal increase in the ammonia level. The forearm exercise test was originally carried out under ischemic conditions; however, we did not conduct the test under ischemic conditions because the diagnostic value is just as good in non-ischemic conditions and muscle injury can be avoided (<xref rid="B9" ref-type="bibr">9</xref>). In addition, several previous studies demonstrated loss of membrane excitability as the amplitude of CMAPs decreased after maximal contracture and high frequency repetitive nerve stimulation, and silent electrical activities during muscle cramping (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). However, we did not identify these findings in the patient presented in this case study. It may be associated with benign clinical symptoms without fixed muscle weakness.</p>
      <p>Second, the serum CK level is elevated in almost all patients with GSD-V even in the absence of exercise. One recent report indicated that hyperCKemia (&gt;200 IU/L) was present in 99% of patients and the majority (79%) of patients had a level greater than 1,000 IU/L (<xref rid="B4" ref-type="bibr">4</xref>). The elevation of serum CK level at rest is likely associated with muscle damage due to impaired glycolysis during exercise. However, the serum CK level at rest did not correlate with clinical severity because exercise-induced muscle damage can stimulate muscle repair and adaptive hypertrophy (<xref rid="B12" ref-type="bibr">12</xref>). In addition, one study demonstrated no significant difference in serum CK level at rest between physically active and inactive patients (<xref rid="B4" ref-type="bibr">4</xref>).</p>
      <p>Third, about half of all patients with GSD-V have experienced one or more episodes of hyperCKemia (several thousand IU/L) or myoglobulinuria after intense exercise. In addition, about 50% of patients with myoglobulinuria develop acute renal failure, which is almost always reversible, but nevertheless requires emergency treatment (<xref rid="B13" ref-type="bibr">13</xref>).</p>
      <p>Fourth, the second-wind phenomenon, an especially unique feature of GSD-V, differentiates GSD-V from other muscle glycogenoses such as muscle phosphofructokinase deficiency (<xref rid="B13" ref-type="bibr">13</xref>). This phenomenon is reported by almost patients during the medical interview. If it is not found in the medical history, it is easily reproduced by diagnostic cycle test (<xref rid="B14" ref-type="bibr">14</xref>). Therefore, it is the key finding that leads to initial suspicion of GSD-V. This phenomenon is caused by an increased supply of glucose and free fatty acids after a long period of exercise. These changes lead to a switch in metabolic pathways from endogenous glycogenolysis to oxidative phosphorylation of blood-borne fatty acids (<xref rid="B15" ref-type="bibr">15</xref>). However, continuing to exercise also results in severe muscle cramps and myoglobulinuria.</p>
      <p>Besides these major clinical features, some patients with GSD-V can also show fixed muscle weakness. Most patients including the patient in this report did not complain of muscle weakness, but approximately one-third of patients develop proximal muscle weakness with aging (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B16" ref-type="bibr">16</xref>).</p>
      <p>Mutation analysis and the myophosphorylase activity assay are used to confirm the diagnosis of GSD-V; however, molecular analysis is more important and more commonly used because muscle biopsy is needed for the enzyme activity assay. At last count in February 2013, 131 different mutations have been reported in the human gene mutation database (<ext-link ext-link-type="uri" xlink:href="http://www.hgmd.org">http://www.hgmd.org</ext-link>). Genotype has not been correlated with the severity of clinical phenotype in previous studies (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). However, there has been a higher incidence of some genotypes in specific ethnic groups; for example, p.R50X and p.G205S in the white population, p.F710del in the Japanese population, and p.W798R in the Spanish population (<xref rid="B13" ref-type="bibr">13</xref>). Likewise, two mutations in our patient have previously been reported in Japan, a neighboring country of Korea (<xref rid="B6" ref-type="bibr">6</xref>). In particular, the p.F710del mutation has been identified in 73% of Japanese patients (<xref rid="B19" ref-type="bibr">19</xref>).</p>
      <p>In conclusion, we identified a compound heterozygous mutation of the <italic>PYGM</italic> in a Korean patient with typical clinical and laboratory findings. We recognize that detailed clinical and laboratory analysis is only the first step in the diagnosis of disease, especially GSD-V.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vieitez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Teijeira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fernandez</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>San Millan</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ortolano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Louis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Laforet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Molecular and clinical study of McArdle's disease in a cohort of 123 European patients: identification of 20 novel mutations</article-title>
          <source>Neuromuscul Disord</source>
          <year>2011</year>
          <volume>21</volume>
          <fpage>817</fpage>
          <lpage>823</lpage>
          <pub-id pub-id-type="pmid">21802952</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimaur</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Andreu</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Bruno</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hadjigeorgiou</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Myophosphorylase deficiency (glycogenosis type V; McArdle disease)</article-title>
          <source>Curr Mol Med</source>
          <year>2002</year>
          <volume>2</volume>
          <fpage>189</fpage>
          <lpage>196</lpage>
          <pub-id pub-id-type="pmid">11949935</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Treatment of McArdle disease</article-title>
          <source>Arch Neurol</source>
          <year>2000</year>
          <volume>57</volume>
          <fpage>923</fpage>
          <lpage>924</lpage>
          <pub-id pub-id-type="pmid">10891971</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Santalla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nogales-Gadea</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Consuegra</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cabello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Teijeira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vieitez</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2012</year>
          <volume>83</volume>
          <fpage>322</fpage>
          <lpage>328</lpage>
          <pub-id pub-id-type="pmid">22250184</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sohn</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sugie</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>A novel PYGM mutation in a Korean patient with McArdle disease: the role of nonsense-mediated mRNA decay</article-title>
          <source>Neuromuscul Disord</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>886</fpage>
          <lpage>889</lpage>
          <pub-id pub-id-type="pmid">18667317</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsujino</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shanske</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nonaka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>DiMauro</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Two mutations, one novel and one frequently observed, in Japanese patients with McArdle's disease</article-title>
          <source>Hum Mol Genet</source>
          <year>1994</year>
          <volume>3</volume>
          <fpage>1005</fpage>
          <lpage>1006</lpage>
          <pub-id pub-id-type="pmid">7951211</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Clausen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vissing</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Reduced levels of skeletal muscle Na+K+-ATPase in McArdle disease</article-title>
          <source>Neurology</source>
          <year>1998</year>
          <volume>50</volume>
          <fpage>37</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">9443454</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clausen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>OB</given-names>
            </name>
          </person-group>
          <article-title>The Na+,K(+)-pump and muscle contractility</article-title>
          <source>Acta Physiol Scand</source>
          <year>1994</year>
          <volume>152</volume>
          <fpage>365</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">7701937</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kazemi-Esfarjani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Skomorowska</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Vissing</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A nonischemic forearm exercise test for McArdle disease</article-title>
          <source>Ann Neurol</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>153</fpage>
          <lpage>159</lpage>
          <pub-id pub-id-type="pmid">12210784</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dyken</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Peake</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>An electromyographic diagnostic screening test in McArdle's disease and a case report</article-title>
          <source>Neurology</source>
          <year>1967</year>
          <volume>17</volume>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">4224654</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorenzoni</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Scola</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Werneck</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>Motor nerve conduction study in McArdle disease: case report</article-title>
          <source>Arq Neuropsiquiatr</source>
          <year>2005</year>
          <volume>63</volume>
          <fpage>874</fpage>
          <lpage>877</lpage>
          <pub-id pub-id-type="pmid">16258675</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clarkson</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Hubal</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Exercise-induced muscle damage in humans</article-title>
          <source>Am J Phys Med Rehabil</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>S52</fpage>
          <lpage>S69</lpage>
          <pub-id pub-id-type="pmid">12409811</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nogales-Gadea</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Andreu</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Arenas</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>McArdle disease: what do neurologists need to know?</article-title>
          <source>Nat Clin Pract Neurol</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>568</fpage>
          <lpage>577</lpage>
          <pub-id pub-id-type="pmid">18833216</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vissing</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>A diagnostic cycle test for McArdle's disease</article-title>
          <source>Ann Neurol</source>
          <year>2003</year>
          <volume>54</volume>
          <fpage>539</fpage>
          <lpage>542</lpage>
          <pub-id pub-id-type="pmid">14520671</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Vissing</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms</article-title>
          <source>Arch Neurol</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>1395</fpage>
          <lpage>1402</lpage>
          <pub-id pub-id-type="pmid">12223025</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolfe</surname>
              <given-names>GI</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Haller</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Burns</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Barohn</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>McArdle's disease presenting with asymmetric, late-onset arm weakness</article-title>
          <source>Muscle Nerve</source>
          <year>2000</year>
          <volume>23</volume>
          <fpage>641</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">10716777</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruno</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cassandrini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Martinuzzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Toscano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moggio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morandi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Servidei</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mongini</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Angelini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Musumeci</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>McArdle disease: the mutation spectrum of PYGM in a large Italian cohort</article-title>
          <source>Hum Mutat</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>718</fpage>
          <pub-id pub-id-type="pmid">16786513</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Rubio</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Buchbinder</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez-Hojas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>del Hoyo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Teijeira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>G&#xE1;mez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fern&#xE1;ndez</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Cabello</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study</article-title>
          <source>Ann Neurol</source>
          <year>2001</year>
          <volume>50</volume>
          <fpage>574</fpage>
          <lpage>581</lpage>
          <pub-id pub-id-type="pmid">11706962</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugie</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sugie</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fukuda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nonaka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Igarashi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Genetic analysis of Japanese patients with myophosphorylase deficiency (McArdle's disease): single-codon deletion in exon 17 is the predominant mutation</article-title>
          <source>Clin Chim Acta</source>
          <year>1995</year>
          <volume>236</volume>
          <fpage>81</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="pmid">7664468</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Pedigree and Sequencing chromatograms in Korean patient with <italic>PYGM</italic> mutations. (<bold>A</bold>) Pedigree of a family with glycogen storage disease type V (GSD-V). Arrow indicates the proband, whose DNA was used for direct sequencing of <italic>PYGM</italic>. Filled symbol indicate affected member. (<bold>B</bold>) Sequencing chromatograms of <italic>PYGM</italic> mutations. One allele had a frameshift mutation of c.1531delG (p.D510fs) in exon 13 and the other allele had a deletion mutation of c.2128_2130delTTC (p.F710del) in exon 17.</p>
      </caption>
      <graphic xlink:href="jkms-29-1021-g001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Non-ischemic forearm exercise test in a patient with GSD-V. The non-ischemic forearm exercise test showed no increase in venous lactate level with a normal increase in ammonia.</p>
      </caption>
      <graphic xlink:href="jkms-29-1021-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
